ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,297Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 2035

$735K Total Retail Price of All Prescriptions

Rank: 124 out of 2035

393 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 393 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 10,797 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LISINOPRIL 529 373 1 3
SIMVASTATIN 439 372 2 1
OMEPRAZOLE 405 305 3 5
METOPROLOL TARTRATE 400 361 4 8
AMLODIPINE BESYLATE 385 346 5 6
CARVEDILOL 349 316 6 22
NEXIUM 300 265 7 51
LEVOTHYROXINE SODIUM 276 179 8 4
WARFARIN SODIUM 274 228 9 11
METFORMIN HCL 265 222 10 9
TAMSULOSIN HCL 244 225 11 25
FUROSEMIDE 238 178 12 7
ISOSORBIDE MONONITRATE ER 225 224 13 32
ATORVASTATIN CALCIUM 222 212 14 13
HYDROCODONE-ACETAMINOPHEN 200 93 S3 15 2
ZOLPIDEM TARTRATE 196 170 16 21
ALENDRONATE SODIUM 185 132 17 27
CLOPIDOGREL 172 157 18 30
PLAVIX 165 152 19 49
RANITIDINE HCL 140 65 20 28
TRIAMTERENE-HCTZ 124 91 21 35
MECLIZINE HCL 124 124 21 147
DIOVAN 121 107 23 76
GLIPIZIDE 116 104 24 54
ATENOLOL 116 76 24 10
METOPROLOL SUCCINATE 114 94 26 16
NIFEDIPINE ER 111 99 27 98
ACETAMINOPHEN-CODEINE 107 104 S3 28 52
LIPITOR 103 102 29 134
HYDROCHLOROTHIAZIDE 100 75 30 12
CRESTOR 96 85 31 41
LOVASTATIN 94 25 32 33
NITROSTAT 93 91 33 167
HYDRALAZINE HCL 92 85 34 45
DOXAZOSIN MESYLATE 89 76 35 111
POTASSIUM CHLORIDE 88 73 36 18
AVODART 83 79 37 225
DIOVAN HCT 82 82 38 126
KLOR-CON M20 82 65 38 73
LOSARTAN-HYDROCHLOROTHIAZIDE 78 74 40 47
DONEPEZIL HCL 78 78 40 24
LOSARTAN POTASSIUM 73 69 42 15
IBUPROFEN 73 54 42 43
AZITHROMYCIN 72 53 44 39
GABAPENTIN 72 54 44 14
PANTOPRAZOLE SODIUM 71 45 46 42
SERTRALINE HCL 70 36 47 23
GLYBURIDE 68 52 R 48 74
ALLOPURINOL 66 64 49 34
LIDODERM 65 41 50 72
POLYETHYLENE GLYCOL 3350 64 49 51 48
PROAIR HFA 62 21 52 31
CLONIDINE HCL 60 59 53 61
TRICOR 59 47 54 120
ADVAIR DISKUS 59 39 54 38
CITALOPRAM HBR 58 47 56 20
DIGOXIN 57 57 57 67
NIFEDICAL XL 55 55 58 290
SPIRIVA 54 36 59 44
ACTOS 52 52 60 124
VERAPAMIL ER 52 50 60 115
SINGLE USE SWAB 52 52 60 163
AMIODARONE HCL 50 50 63 171
SYNTHROID 50 39 63 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.